Metraipolis › archive › dc_af481663e5e7

Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities — Europe PMC PMID:41599233

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41599233
DOI: 10.3390/pharmaceutics18010126
License (as archived): solo-consultazione
Archived: 2026-11-06T17:24:09.378Z
SHA-256 of the archived text: e43625543c84b0d548f2ef9727c8129fd6a05e2f0f4e1cac503ebd275d315d2a
Stable URL of this page: https://metraipolis.com/documento/dc_af481663e5e7

How to cite

Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities — Europe PMC PMID:41599233 — Europe PMC (en), https://europepmc.org/article/MED/41599233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af481663e5e7 (Metraipolis archive dc_af481663e5e7, sha256 e43625543c84b0d548f2ef9727c8129fd6a05e2f0f4e1cac503ebd275d315d2a)

BibTeX

@misc{dcaf481663e5e7,
  title = {Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities — Europe PMC PMID:41599233},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41599233},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af481663e5e7; sha256 e43625543c84b0d548f2ef9727c8129fd6a05e2f0f4e1cac503ebd275d315d2a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599233. Agents can read the archived copy with the MCP tool read_document.